Author:
Flavio Gomes Jardim Filho Marcelo
Abstract
Heyde’s Syndrome is a clinical condition characterized by the coexistence of aortic stenosis and gastrointestinal bleeding, typically associated with angiodysplasia. This study reviews recent literature, highlighting the relationship between aortic stenosis and the degradation of von Willebrand factor (vWF), leading to the development of acquired von Willebrand disease (AVWD). The review addresses the key biochemical parameters and diagnostic methods used for identifying the syndrome, emphasizing the importance of echocardiography for detecting aortic stenosis and multimer analysis of vWF for confirming AVWD. The analysis includes discussions on the diagnostic challenges and clinical implications of the syndrome, proposing guidelines that could improve therapeutic management and reduce associated morbidity. It concludes that an integrated, evidence-based diagnostic approach is essential for the early detection and effective treatment of Heyde’s Syndrome.
Reference20 articles.
1. BASAK, D. K.; GOMES, R. R.; ARFIN, S., Md. Heyde’s syndrome: Rarely heard and often missed. Advanced Research in Gastroenterology & Hepatology, Vol. 2, No. 4, 2017. DOI: 10.19080/argh.2017.02.555592.
2. BLACKSHEAR, J. L. et al. Indexes of von Willebrand Factor as Biomarkers of Aortic Stenosis Severity (from the Biomarkers of Aortic Stenosis Severity [BASS] Study). The American Journal of Cardiology, v. 111, n. 3, p. 374-381, 2013. DOI: 10.1016/j.amjcard.2012.10.015.
3. BUDDE, U.; SCHNEPPENHEIM, R. Acquired von Willebrand syndrome in patients with high shear stress: from quantitative loss of von Willebrand factor to qualitative defects. Seminars in Thrombosis and Hemostasis, v. 34, n. 5, p. 520-528, 2008. DOI: 10.1055/s-0029-1145245.
4. CARITÀ, P.; COPPOLA, G.; NOVO, G. et al. Aortic stenosis: insights on pathogenesis and clinical implications. Journal of Geriatric Cardiology, v. 13, p. 489-498, 2016. DOI: 10.11909/j.issn.1671-5411.2016.06.001.
5. GIANNINI, S. et al. Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythemia - affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. Thrombosis and Haemostasis, v. 105, n. 5, p. 921-924, 2011. DOI: 10.1160/th10-08-0517.